Petra Budde

885 total citations
36 papers, 648 citations indexed

About

Petra Budde is a scholar working on Radiology, Nuclear Medicine and Imaging, Rheumatology and Immunology. According to data from OpenAlex, Petra Budde has authored 36 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Rheumatology and 12 papers in Immunology. Recurrent topics in Petra Budde's work include Monoclonal and Polyclonal Antibodies Research (20 papers), Systemic Lupus Erythematosus Research (13 papers) and Advanced Proteomics Techniques and Applications (6 papers). Petra Budde is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), Systemic Lupus Erythematosus Research (13 papers) and Advanced Proteomics Techniques and Applications (6 papers). Petra Budde collaborates with scholars based in Germany, United States and Sweden. Petra Budde's co-authors include J Frey, Katja Tœnsing, Eberhard Neumann, Sergej Kakorin, Jürgen Frey, Harald Tammen, Peter Schulz‐Knappe, Hans‐Dieter Zucht, Rüdiger Hess and Susheela Tridandapani and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Petra Budde

33 papers receiving 628 citations

Peers

Countries citing papers authored by Petra Budde

Since Specialization

Citations

This map shows the geographic impact of Petra Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Budde more than expected).

Fields of papers citing papers by Petra Budde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Budde. The network helps show where Petra Budde may publish in the future.

Co-authorship network of co-authors of Petra Budde

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Budde. A scholar is included among the top collaborators of Petra Budde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Budde. Petra Budde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors	ESMO Open	Joud Hajjar, Bettzy Stephen et al.	1
2	Identification of novel autoantibodies in Sjögren’s disease	Frontiers in Immunology	Petra Budde, Thomas Dörner et al.	0
3	TLR7/8 Activation in Immune Cells and Muscle by RNA‐Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis	Arthritis & Rheumatology	Yin Wu, Nicholas Geraci et al.	6
4	Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer	Journal for ImmunoTherapy of Cancer	Praful Ravi, Dory Freeman et al.	2
5	Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection	Journal of Translational Medicine	Yunxian Liu, Joseph E. Ebinger et al.	42
6	Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany	Arthritis Research & Therapy	Stefan Vordenbäumen, Ralph Brinks et al.	4
7	Autoantibodies as predictors for survival and immune-related adverse events in checkpoint inhibition therapy of metastasized melanoma.	Journal of Clinical Oncology	Jessica C. Hassel, Hans‐Dieter Zucht et al.	5
8	Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients	The Pharmacogenomics Journal	Stephanie F Ling, Nisha Nair et al.	9
9	SAT0098 ANTIBODIES AGAINST CITRULLINATED ANTIGENS ARE ASSOCIATED WITH TREATMENT RESPONSE IN ACPA-NEGATIVE RHEUMATOID ARTHRITIS PATIENTS	Annals of the Rheumatic Diseases	Stephanie F Ling, Nisha Nair et al.	0
10	High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus	Lara D. Veeken	Stefan Vordenbäumen, Ralph Brinks et al.	10
11	Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis	Arthritis Research & Therapy	Stefan Vordenbäumen, Angelika Lueking et al.	13
12	In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma	Biochemical Pharmacology	Marco Jost, Jens Lamerz et al.	24
13	Oncopeptidomics – A commentary on opportunities and limitations	Cancer Letters	Harald Tammen, Hans‐Dieter Zucht et al.	11
14	Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas	Laboratory Investigation	Frank Traub, Marco Jost et al.	29
15	The Concept of Functional Peptidomics for the Discovery of Bioactive Peptides in Cell Culture Models	Combinatorial Chemistry & High Throughput Screening	Marco Jost, Petra Budde et al.	13
16	Prerequisites for Peptidomic Analysis of Blood Samples: II. Analysis of Human Plasma after Oral Glucose Challenge - A Proof of Concept	Combinatorial Chemistry & High Throughput Screening	Harald Tammen, Rüdiger Hess et al.	15
17	Peptidomics Biomarker Discovery in Mouse Models of Obesity and Type 2 Diabetes	Combinatorial Chemistry & High Throughput Screening	Petra Budde, Imke Schulte et al.	20
18	Structural domains required for channel function of the mouse transient receptor potential protein homologue TRP1β	FEBS Letters	Michael Engelke, Petra Budde et al.	39
19	Elevated expression of membrane type 1 metalloproteinase (MT1‐MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system	FEBS Letters	Silvia Rathke‐Hartlieb, Petra Budde et al.	31
20	Mechanism of Electroporative Dye Uptake by Mouse B Cells	Biophysical Journal	Eberhard Neumann, Katja Tœnsing et al.	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact